German Regulatory Updates And Digital Rx Adoption Will Transform Healthcare

Published
30 Dec 24
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
€163.67
37.6% undervalued intrinsic discount
08 Aug
€102.20
Loading
1Y
-26.5%
7D
3.8%

Author's Valuation

€163.7

37.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 12%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 2.08%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 2.69%

AnalystConsensusTarget has decreased profit margin from 2.5% to 1.7% and increased future PE multiple from 33.8x to 50.6x.

Shared on12 Mar 25
Fair value Decreased 5.68%

AnalystConsensusTarget has increased profit margin from 2.1% to 2.5% and decreased future PE multiple from 43.7x to 33.8x.